MedAdvisor

MedAdvisor LT Debt/Equity

Delisted

The Long-Term Debt to Equity Ratio of MedAdvisor (MDR.AX) as of Oct 18, 2026 is 16.51.

LT Debt/Equity

16.51

Last updated:

Long-Term Debt to Equity Ratio of MedAdvisor is 2025 16.51 . Long-Term Debt to Equity Ratio of MedAdvisor was 2024 0.00 . It decreases by % higher compared to the previous year.

The MedAdvisor LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2018
0.00 AUD
Jan 1, 2019
0.00 AUD
Jan 1, 2020
0.07 AUD
Jan 1, 2021
0.16 AUD
Jan 1, 2022
0.23 AUD
Jan 1, 2023
0.25 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025
16.51 AUD
The MedAdvisor LT Debt/Equity history
YEARLT Debt/EquityYoY
16.51—
0.00-100.00%
0.25+10.24%
0.23+46.98%
0.16+125.81%
0.07—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MedAdvisor Stock analysis

What does MedAdvisor do? Medadvisor Ltd is an Australian company that offers a digital platform for healthcare. Founded in 2012 by Robert Read, David Liu, and Josh Swinnerton, their aim was to develop a platform that simplifies medication management for patients, pharmacies, and doctors. Today, Medadvisor is a publicly traded company with a wide range of digital healthcare solutions. They offer various solutions to support patients in medication intake and management, such as a mobile application that allows patients to manage their medications, order prescriptions, and receive reminders. They also offer solutions for pharmacies, including an online ordering system and access to electronic patient history, as well as a platform for doctors to electronically issue prescriptions. One of their latest products is a mobile application that facilitates the handling of COVID-19, providing real-time virus spread tracking and symptom tracking tools. Medadvisor focuses on meeting customer needs and continuously improving the healthcare process. They recently partnered with Take2 Healthcare to expand their range of solutions and create the best offering of health solutions. Overall, Medadvisor plays an important role in the Australian healthcare system by helping their customers live happier and healthier lives through innovative technologies and services. MedAdvisor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedAdvisor stock

Long-Term Debt to Equity Ratio of MedAdvisor is 16.51 in 2025.

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio MedAdvisor since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's MedAdvisor with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — MedAdvisor

All Key Metrics — MedAdvisor